Haemonetics | HAE - Ordinary Share Capital


Haemonetics reported $46.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Avanos Medical USD 46.46M 39.46K Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 195.1M 3.71M Dec/2025
Fresenius EUR 563.24M 0 Sep/2025
Fresenius Medical Care EUR 279.29M 10.56M Dec/2025
Globus Medical USD 135.06M 449K Dec/2025
Haemonetics USD 46.83M 82K Dec/2025
Hologic USD 222.57M 350K Sep/2025
ICU Medical USD 24.69M 2K Dec/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
Masimo USD 52.1M 1000K Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Neogen USD 217.53M 227K Sep/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Quidel USD 67.9M 200K Sep/2025
ResMed USD 145.97M 25K Dec/2025
STAAR Surgical USD 49.4M 49K Dec/2025
Steris USD 98.15M 344K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Surmodics USD 14.3M 13.58M Jun/2025
Teleflex USD 44.19M 1000 Dec/2025
Terumo JPY 1.48B 0 Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
US Physical Therapy USD 15.2M 0 Sep/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025